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Summary.-Intact cells of various human tumours and tumour cell lines, and acid
extracts of various human tumours and normal tissues, each of which react with the
lymphocytes of cancer patients as detected by the macrophage electrophoretic
mobility (MEM) test, have been subjected to proteolysis. Activity was destroyed by
some enzymes, and the apparent molecular size of the active material was reduced
by others. An active low-mol.-wt fragment has been partially purified from papain
digests of several tumours. Peptides with normal tissue and tumour-characteristic
activities have been separated chromatographically from tryptic digests of tumour
extracts.
SINCE ITS INTRODUCTION (Field & Cas-
pary, 1970) the macrophage electrophor-
etic mobility (MEM) assay has generated
controversy because of the problems of
establishing the assay in other labora-
tories. The subject has been reviewed
(Moore & Lajtha, 1977) and been the
major subject of 2 recent symposia
(Muller, 1978; Preece & Sabolovic, 1979).
The consensus from these appraisals is that
the basic observations are essentially cor-
rect and repeatable in favourable circum-
stances.
The justification for regarding the MEM
assay as a measure of an immune response
has been examined (Dickinson, 1979) and
rests on the necessity for the presence of
lymphocytes; the lymphokine-like mech-
anisms of the assay; the small fraction of
peripheral-blood lymphocytes responding;
the demonstration of antigen specificity in
in vitro "sensitization" and in the pattern
of reactivity to extracts of tumours of
particular sites by cancer patients' lym-
phocytes; the specificity and time course
ofgeneration of the response in artificially
immunized animals; and finally on some
anecdotal evidence for the long-lived
anamnestic nature ofthe response. Against
this background it seems acceptable to
refer to materials provoking a response in
the MEM assay as antigens.
Two such antigens, readily extracted
with acid from human tissues and cross-
reactive in the MEM test, have been pre-
viously noted (Caspary & Field, 1971;
Dickinson et al., 1974). The suggested
universal occurrence of one (variously
termed the common tumotur-specific anti-
gen, cancer basic protein, CaBP and
cancer EF, and here referred to as the
tumour antigen) in human malignant
tissues was discussed by Caspary (1972)
and is supported by all our subsequent
investigations. The other, which appears
to be present in all human tissues, is simi-
larly referred to here as normal tissue
antigen. These two antigens are detected
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by their activity in the MEM test when
lymphocytes from patients with solid
malignant tumours are used as responding
cells, and are qualitatively distinguished
by the different plateau values of macro-
phage slowing which they give (Carnegie
et al., 1973).
Some properties of these two antigens
have been noted previously. Thus the
tumour antigen appears to be restricted
in vivo to malignant neoplasias (Dickinson
et al., 1973); the 2 antigens show simi-
larities in terms of proteolipid nature,
basicity, localization on the external sur-
face of the plasma membrane, and
molecular size (- 17,000 daltons) (Dickin-
son et al., 1974; Dickinson et al., 1972).
The cross-reactivity of the two antigens
has been investigated using immuno-
sorbent techniques (McDermott et al.,
1974).
Some of the properties previously de-
scribed have depended on the tacit
assumption that each antigen is a simple
protein. The experiments presented here
attempt to justify this assumption and
also represent the start ofan attack on the
problem of defining the primary struc-
tures responsible for antigenic activity.
MATERIALS AND METHODS
Whole tumour cells.-HeLa, HeLa-S3, Hep-
2 and FL cells were grown in monolayer cul-
tures by standard techniques, except that the
final harvest was effected, as previously, with
buffered versene alone (Dickinson et al., 1972).
Leucocytes obtained during therapeutic
leucopheresis from 3 patients with chronic
lymphocytic leukaemia were received as
saline-washed, packed and snap-frozen cells.
Acid extracts of solid tumours.-These were
prepared separately as previously described
(Dickinson et al., 1973) from fresh surgical
specimens (subsequently histologically assess-
ed) of human carcinomas of stomach (3),
colon (2), breast (5), vulva, cervix uteri,
kidney and bronchus, from a carcinomatous
mass in the omentum, and from a pool of
various formalin-fixed tumours (Pool).
Guinea-pig hepatoma was a kind gift from
Dr M. Dale. Extracts were also prepared from
the following normal human tissues obtained
at surgery: spleen, breast (3), stomach, colon
(2), kidney, term placenta and lung, from
unfixed grossly normal liver obtained at
necropsy and from normal guinea-pig liver.
The activities in the MEM test ofa number of
these extracts have been specifically noted in
previous papers in this series; each extract
was tested and shown to be active before
further use.
Enzymes.-Trypsin. Four types of trypsin
were used: (i) DIFCO trypsin 1: 250; (ii)
trypsin Type III (Sigma Chemical Co.);
(iii) DCC-trypsin Type III (Sigma), in which
chymotrypsin had been inhibited by treat-
ment with the selective inhibitor diphenyl-
carbamyl chloride; (iv) Enzygel-trypsin
(Boehringer, Mannheim) which was treated
with 1-(4-tosylamido)-2-phenylethyl chloro-
methyl ketone (TPCK) to inactivate residual
chymotrypsin (Carpenter, 1967).
Pronase (British Drug Houses) and pro-
tease (Subtilisin BPN) Type VII, ox-chymo-
trypsin Type II, pepsin (1: 60,000) and papain
2 x recrystallized (all from Sigma) were used.
Papain was activated by incubation for 10
min at 37°C in a small volume of the appro-
priate buffer containing 1 mg sodium cyanide
for each 2-5 mg of enzyme protein before
addition to the material to be digested.
Assay of antigenic activity.-The macro-
phage electrophoretic mobility (MEM) assay
was described previously (Dickinson et al.,
1973). Lymphocytes from patients bearing
solid malignant tumours which were, pro tem.,
untreated, were used exclusively. Results are
expressed as macrophage slowing relative to
the slowing given by a reference antigen
tested at the same time against the same
lymphocytes and macrophages, and taken
arbitrarily as 100. Details of reference anti-
gens are given by Dickinson et al. (1974).
Chromatography.-G-10, G-15 and G-50
grades of Sephadex (Pharmacia, Uppsala)
were used. The dextran beads were swollen in,
and columns generally packed, washed and
eluted with, O-O1M ammonia; void volumes
were determined with Blue Dextran 2000.
Neutral cellulose (Cellex-MX or -Ni) was
from Bio-Rad Laboratories Limited. Pre-
parative chromatograms were run on What-
man No. 1 or 3MM paper which had been
washed by descending flow ofO-O1M ammonia,
allowing at least 4 ml/cm width to drip from
the bottom of the paper: the papers were
carefully air-dried before use. Peptide
chromatograms were developed with n-
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butanol:acetic acid:water (BAW, 12:3:5 by
volume), and selected bands eluted with
O01OM ammonia. Analytical chromatograms
of proteolytic-enzyme digests were run on
No. 1 paper in BAW, and visualized with
ninhydrin.
Enzymic dige.qtion of whole cells
Trypsin.-Versene-harvested Hep-2 cells
were washed x3 with Parker Medium 199
(Bio-Cult Limited) suspended in cold (4°C)
Dulbecco phosphate - buffered saline - A
(PBSA) containing 10mM versene (pH 7.2) to
give, after the addition of trypsin (DIFCO)
to 0.125%, a final concentration of 1-3 x 106
cells/ml: the concentration and quality of
trypsin were those in routine use for cell cul-
ture. After incubation at 37°C for periods
from 0 to 18 h, aliquots were centrifuged and
the pellets washed once with Eagle's complete
medium containing 10% foetal calf serum.
Total and viable counts (by trypan blue
exclusion) were made and, after two further
washings with Medium 199, cells for testing
were frozen. The first supernatants were
fractionated on G-50, low-mol.-wt material
being collected for testing.
Papain-time course.-Hep-2 cells were
digested at 37°C in sodium acetate (0-2M, pH
4-0) with 1 mg cyanide-activated papain/108
cells. At appropriate times aliquots were re-
moved and the particulate material collected
and washed for testing. The first super-
natants were fractionated on G-50 and G-10
(see Purification of fragments, below).
Papain preparations.-Versene-harvested
HeLa-S3 and FL cells and washed leukaemic
lymphocytes were digested with papain at
37TC in sodium acetate at pH 4 0 for periods
from 3 to I8 h and at enzyme-substrate ratios
ranging from 80 to 0-05 mg papain/109 cells.
The digests were clarified by centrifugation
at 18,000 g max., and the supernates frac-
tionated as described below.
Enzymic digestion of acid extracts
Trypsin.-The effect of crude trypsin on
the antigenic activity ofwhole cells described
above suggested that, since inactivation of
material in the supernate was a good deal
slower than the rate of removal from the cell
surface, the inactivation might be due to
chymotryptic or other proteolytic impurities
in the trypsin. An acid extract of a tumour
(1 mg) was therefore digested with a com-
mercial preparation of chymotrypsin-inhibit-
ed trypsin, i.e. DCC-trypsin (200 ,ug) in
200 -lI 01M ammonium bicarbonate at 37°C
for 2 h. The digest was fractionated on G-50
and the low-mol.-wt material tested. The
same acid extract (1 mg) was also digested for
7 h at 37°C in 01M ammonium bicarbonate
(2 ml) with 50 (BAE) units of an Enzygel-
trypsin preparation which had been treated
with TPCK to inactivate chymotrypsin. The
simple digest supernate was tested; digestion
was demonstrated by paper chromatography,
and the mobilities of the active materials
determined.
The stability of normal tissue antigen to
non-chymotrypsin-inhibited trypsin was also
investigated. The crude acid extract and the
active fraction from G-200 of normal liver
were digested with trypsin Type III and
DCC-trypsin, respectively, and the low-mol.-
wt fractions from G-50 tested for activity.
Papain.-An acid extract of a tumour was
digested at 37°C with papain (4 mg extract/
mg papain) in tris-HCl buffer (0-2M) at pH
8.0, 7 0 and 6-0, and in sodium acetate (0.2M)
adjusted to pH 5 0 and 4-0 with acetic acid.
The digests were fractionated on G-50 and
G-15 and tested for activity. Further tumour
extracts were digested at 20 to 260 mg
extract/mg papain, the digests fractionated
as described below, and the fractions tested
for activity. Acid extracts of normal tissues
were also digested at pH 4-0 with papain
(12-160 mg substrate/mg papain) and the
fractionated digests tested for activity.
Other proteinases.-Extracts of normal and
tumour tissue were digested with (i) chymo-
trypsin in 01M ammonium acetate (pH 8.8)
containing 5 mm Ca++; (ii) pepsin in 01M
HCI, or at higher pepsin: substrate ratios in
0-5M formic acid; (iii) subtilisin or pronase in
01M ammonium bicarbonate. The low-mol.-
wt materials from G-50 were tested for
activity, or in the case of pepsin the frozen
dried digests were tested directly.
Purification of active papainfragments
Papain digests, prepared as noted above,
were clarified by centrifugation at 18,000 g
for 20 min and the supernates fractionated by
gel filtration on G-50 in O-O1M ammonia. The
active fraction was concentrated and further
fractionated on G-15 or G-10 in the same
solvent and the active fraction lyophilized.
Subsequent treatment varied according to
the bulk of material obtained in the activeA COMMON TUMOUR SPECIFIC ANTIGEN
fraction. When the bulk was small, the active
fraction (Pap 3A-see Fig. 2) was loaded on
3MM paper and chromatographed with BAW
in the descending mode. After drying, guide
strips were stained with ninhydrin; the main
part of the chromatogram was divided into
strips corresponding to 041 or 0 05 Rf inter-
vals which were eluted with OO1M ammonia.
Eluates containing active material were con-
centrated and re-run otf No. 1 paper in the
same solvent, and activity recovered in the
same way.
When active fractions from G-15 were of
large bulk (e.g. from digests of leukaemic
cells) the primary chromatography step was
carried out on packed columns of neutral
cellulose prepared by suspending the dry
cellulose in the lower phase of an n-butanol:
acetic acid:water (4:1:4 by volume) mixture,
and packing in a solvent-resistant column
(SR-35, Pharmacia Limited, Uppsala). After
washing with 2-3 column volumes of lower
phase, the column was washed and equili-
brated with upper phase. Samples were
applied dissolved in a minimum volume of
lower phase, and the column eluted with
upper phase. Fresh cellulose was used for each
separation. The absorbence of the column
effluent was monitored at 280 nm. Effluent
fractions were diluted with water and
lyophilized. Active inaterials were further
fractionated by chromatography on 3MM or
No. 1 paper as detailed above.
RESULTS
The results of the MEM assay with the
reference antigens and lymphocytes from
patients with malignancy used in these
investigations were analysed previously
(Dickinson et al., 1974).
It should be emphasized that in this
present context antigen or antigenic
activity implies no more than the ability
to release from the lymphocytes of known
cancer bearers a factor which causes a
reduction of electrophoretic mobility of
particular (Shenton, Hughes & Field,
1973) oil-induced peritoneal macrophages
of guinea-pigs. This factor is rarely re-
leased bv the lymphocytes of young,
apparently healthy individuals. The inter-
pretation of the data to be presented is
dependent on the nature of the dose-
19
response relationship of the MEM assay
(Carnegie et al., 1973). Unlike responses in
many assays of cell-mediated immunity,
excess antigen over a very wide concen-
tration range does not inhibit the response
(slowing of macrophages) and the plateau
response depends on the qualitative nature
of the antigen. Further, a considerable
excess of an antigen giving a lower re-
sponse (e.g. normal tissue antigen) does
not mask or reduce the response generated
by an antigen giving a higher response,
e.g. common tumour antigen (Dickinson
et al., 1973).
Susceptibility of antigen activities to
digestion with proteolytic enzymes
The results of testing appropriate frac-
tions after digestion of acid extracts of
various tumours and normal tissues with
a variety of proteolytic enzymes are given
in the Table. In each case proteolysis was
demonstrated by comparative paper
chromatography of the starting materials
and their unfractionated digests. The
fractionations of digests on G-50 were
arranged so that enzyme and undigested
active materials were rejected in a high-
molecular-mass fraction and low-molecu-
lar-mass (< 6000 daltons) peptide mat-
erial was recovered for assay. Relative
slowings obtained with a dose of materials
derived from 100 jig of original acid ex-
tract are given. Thus, if the low-mol.-wt
fraction ofa digest gives a relative slowing
within the appropriate range (85-110 for
tumour and 45-75 for normal tissue anti-
gen), proteolysis has taken place, but
cleavage of peptide bonds involved in the
determinant is incomplete. Conversely, a
relative slowing of less than 30 indicates
the virtually complete cleavage of the
determinant, since of the original acid
extracts generally less than 0*l ,ug causes
maximal slowing.
The results given in the Table suggest
that (i) the molecular size of the active
material is reduced by digestion with pure
trypsin, pronase and subtilisin, and with
papain in moderately acid conditions, but
that the determinant contains no bonds
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TABLE.-Proteolytic enzyme digestion of acid extracts of human carcinomas and normal
tissues
Relative slowing
Enzyme
Retaining activity-
Carcinomas
Trypsin-TPCKt
Pronase
Subtilisin
Papain pH 4-0
pH 5-0
Normal Tissues
Trypsint
Trypsin DCC§
Pronase
Subtilisin
Destroying Activity-
Carcinomas
Trypsin-DCC
PepsinT
Chymotrypsin
Pepsintt
Pepsintt
Papain pH 6-0
pH 7 0
Normal Tissues
Chymotrypsin
Papain pH 4-0
Pepsintt
Sourcv
Kidney
Kidney
Kidney
Kidney
Kidney
Liver
Liver
Placenta
Placenta
Kidney
Breast
Pool-2
Kidney
Pool 2
Kidney
Kidney
Liver
Liver
Liver
Substrate/
enzyme
ratio§
50*
'3
1 2
1-2
12-
8
10
10
10
15
20
2
1 2
0-25
1*2
1 2
6
I)igestion
time
(0)§
7
1*5
15
1*5
1l5
5
72
6
6
1.5
3
15
3
15
1*5
5
3-5
Before
(ligestion
94/9**
94/9**
94/9**
94/9**
94/9**
69
69
69
69
94/9**
95
98
94/9**
98
94/9**
94/9**
69
5
'3
Digest
Whllole Low-mol._ t
100
T+ 109
108
96
-++
69
71
63
75
80
67
26
8
4
10
14
8
69 21
t Insolubilized trypsin, treat,ed with TPCK to iniactivate chlymotrypsin.
t Trypsin SigmaType III, with chymotryptic activity.
§ Trypsin-DCC Sigma Type III, treated with ineffectixve chlymotryptic illhibitor I)CC.
¶ Pepsin buffered with HCI.
tt Pepsin buffered with formic acidl.
+1 No observation; No assay is possible with unfractionated digests containing still-active proteolytie
enzymes which would attack both lymplhocyte surfaces and released lympllokines.
§§ Enzyme concentrations, times andl enzyme/substiate ratios uised are greater than recomnmen(led for
peptide preparation and sequencing stui(lies (ef Methods in Enzymology, AVols XIV an(c XIX).
* BAE u/mg.
** High/Low-mol.-wt fiactions from G-50 of extract incubat,ed for 1-5 hi at 37°C in 0-2M ammonium
bicarbonate.
Digestions of acid extracts in conditions appropriate to each enzyme were made and aliquots run on
No. 1 paper in BAW and visualized with ininhydrin to check for effectix-e proteolysis. Some (ligests were
separated into lilglh- (containing enzyme and possibly undigested material) and low-mol.-wt fiactions before
assay for activity. Relative slowings given by the low-mol.-wt fractions, wuhole (i.e. uinfractionated) (ligests
and untreated acid extracts at closes eqtivTalent to 100 ,Lg of acid extract,.
completely susceptible to these enzymes;
(ii) the active material and the determi-
nant contain bonds susceptible to chymo-
trypsin and pepsin, and to papain at
neutrality. The possibility that proteo-
lysis of the active material (as opposed to
the inactive part of the extract) had not
taken place was excluded in the case of
pepsin by testing the unfractionated
lyophilized digests in formic acid (pepsin
is inactive at neutrality) which were like-
wise inactive. This same possibility cannot
be formally excluded in the case of the
chymotryptic and neutral papain digests,
but seems unlikely. Further experiments
with sequential proteolytic digestions,
which tend to confirm the susceptibilities
reported here, will be reported separately.
It may be concluded that the activity is
associated with polypeptides; that the
determinant is, at least in part, peptide in
nature carrying essential peptide bondsA COMMON TUMOUR SPECIFIC ANTIGEN
5 1iS
;inetubata twrw.-
FiG. l.-Digestion of HeLa cells with trypsin.
Separation of cells fiom trypsin-containing
supernatants was beguin at the indlicate(d
times. The total count an(d proportion of
v-iable (ells at various times are recordedl;
the relativ e slowings gi-en by 105 separatedl
anIl washied cells anil by fractionated
supernates dlerive(l from 106 cells are gixenl.
C ... O, cell couint; *-*, viability;
0 ... c, cell residue (1 0-); * *, super-
inatanit (106).
involving aromatic amino acids; and that
the determinant is considerably smaller
than the whole antigen.
Removal of antigenic activity from the
surface oftumour cells byproteolytic enzymes
The results of digestion of HeLa cells
with impure trypsin are shown in Fig. l.
At times up to 5 h the total cell count is
fairly constant and > 85% of those cells
still exclude trypan blue. However, the
antigenic activities of the cells and the
low-mol.-wt fractions of the supernates
have changed markedly by 2-5 h, both
having activity in the normal tissue anti-
gen range. After 18 h the cells, surprisingly
still excluding trypan blue, have lost all
antigenic activity as detected by the MEM
test, but the supernate still retains
activity in the normal tissue antigen range.
Thus it is seen that the impure trypsin in
the conditions generally used for harvest-
ing tumour-cell lines grown in monolayer
culture readily removed the tumour anti-
gen from the surface ofliving tumour cells,
and that even digestion at room tempera-
ture for 5 min (the minimum contact
allowed during the centrifugation and
separation steps), and represented by the
time zero ordinate ofFig. 1, has brought a
significant proportion of the tumour anti-
gen into solution. In contrast, versene
harvesting has been shown not to remove
antigen from the surface of tumour cells
(Dickinson et al., 1972).
The inactivation of the tumour antigen
activityinthe supernatants, which appears
to take place more slowly than the release
into solution, is probably due to the pres-
ence of chymotrypsin in the DIFCO
trypsin. Further evidence to this effect is
given in the Table, which shows that whilst
chymotrypsin readily inactivates the
tumour antigen, a fully chymotrypsin-
inhibited trypsin preparation (Enzygel-
TPCK trypsin) does not, whereas a com-
mercial preparation (DCC-trypsin) is less
effectively inhibited, leaving normal tissue
antigen still active in the digest.
After digestion of Hep-2 cells with
papain at pH 4-0 for 1.5, 3 0 and 18 h, the
cell residue, tested at 106 cells/test, gave
relative slowings of 90, 71 and 42 respec-
tively. The appropriate fraction of each
supernatant was found to contain activity
in the tumour-antigen range. It appears
that with an enzyme-substrate ratio of
1 mg papain/108 cells, 3h incubation is
adequate to bring all the tumour-specific
activity into solution in low-mol.-wt form.
Partial purification of the active papain
fragment
Clarified papain (pH 4.0) digests of
whole cells, or acid extracts of cells or
malignant or normal tissues, were frac-
tionated by chromatography successively
on G-50, G-15 and cellulose (either as
packed columns or as paper). Separations
are illustrated in Fig. 2a, 2b and 3. The
only active fraction from G-50 (Pap 3)
would contain peptide material < 6000
daltons, and that from G-15 (Pap 3A)
would contain peptide material of > 2000
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FIG. 2. Gel filtration of papain digest
(representative traces). 240 mg of acid
extract of a colonic carcinoma in 10 ml
buffer was digested during 24 h with 6 mg
papain at 370C and pH 4 0. (a) Sample
applied to 220ml-bed-volume column of
Sephadex G-50 and eluted with 0-01 M
ammonia at 20 ml/h; 7-5 ml fractions col-
lected and pooled as indicated. (b) lyo-
philized fraction Pap 3 of Trace (a)
dissolved in 6 ml O-OM ammonia, applied
to 100ml column of G-10 and eluted with
O-O1M ammonia at 20 ml/h; 3 ml fractions
collected and pooled as indicated.
daltons. Papain is removed in fraction
Pap 1 and buffer salts in fraction Pap 3C.
Chromatography ofPap 3A fractions on
paper showed that from each of the 20
individual human carcinomas tested
(stomach-3, colon-2, breast 5, vulva,
cervix uteri, kidney, bronchus, a mass in
omentum, HeLa cells, Hep-2 cells-I of
each, and chronic lymphocytic leukaemic
leucocytes-3) from guinea-pig hepatoma
and from pooled human tumour tissues
containing many different carcinomas,
tumour-type activity was found only in
the region from Rf 0-85 to 10, and most
commonly from Rf 0 90 to 0 95, and was
not associated with ninhydrin-positive
material. The vast bulk of ninhydrin-
positive material was dispersed in various
bands from Rr 0-0 to 0-6, and thus this
0
Rf0 45
Rf 06
fraction pap 3A.cell 1
I I1
fraction no.
FIG. 3. Chromatography on a neutral cellu-
lose column of active fraction Pap 3A from
leukaemic leucocytes; 180ml-bed-volume
column of Cellex N-1 prepared, loaded and
eluted as described in the Methods section;
flow rate 25 ml/h; 2-5 ml fractions.
Adapted from a "Uvicord" trace. The peak
of absorbance at fractions 11-13 is due
to the breakthrough of the aqueous load-
ing solvent as a biphasic mixture. Aliquots
of individual fractions were run on No. 1
paper in BAW and stained with ninhydriin;
the approximate mean Rf values of major
ninhydrin-positive spots are given for the
indicated groups of fractions. The pooled
"Pap 3A-Cell-l" fraction was the only
eluted material with activity (relative
slowing 101).
separation step is extremely effective in
increasing the specific activity ofthe active
fragment, since the weights of material
recovered from the active region of the
chromatograms were unmeasurably small.
The separation procedure was successfully
scaled up to column size, and a repre-
sentative separation is illustrated in Fig. 3.
On no occasion has normal tissue-type
activity been separated from tumour-type
activity by chromatography of Pap 3A
fractions of digests of tumour extracts.
Fractionation of papain digests of
normal guinea-pig liver and of normal
human tissue to Pap 3A stage gave in 5
instances (liver, stomach, colon and breast
-2) no residual activity and in 8 instances
(guinea-pig liver, liver, spleen, breast,
kidney, lung, stomach and placenta)
normal tissue-type activity which was
further shown to have Rf > 0-65 in BAW.A COMMON TUMOUR SPECIFIC ANTIGEN
The 2 groups of results divide clearly
according to the particular batch of
papain used for the digestion. Substrate-
enzyme ratios used were similar (3 to 50:1
and 3 to 40:1) but the papain preparation
which allowed recovery of activity was
the purer on the basis of twice the specific
activity against benzoyl arginine ethyl
ester. Since the less pure batch is no longer
available, the point cannot be further re-
solved, but it leaves a slight problem for
the purification of the tumour-antigen
papain fragment, since the two active
fragments appear to have similar Rf
values.
Partial purification of the active tryptic
fragment
A mixture of active acid extracts from
several tumours was digested with TPCK-
treated Enzygel trypsin in 0 IM am-
monium bicarbonate. The supernate was
lyophilized and run on No. 1 paper in
BAW. Normal tissue-type activity was
found mainly between Rf 0-15 and 0-20
(Relative Slowing 50) and tumour-type
activity between Rf 0-25 and 0 30 (Rela-
tive Slowing 88).
DISCUSSION
Two antigenic activities which appear
to be associated with all malignant tissues
(tumour antigen) and with normal tissue
in vivo (normal tissue antigen) have pre-
viously been described. The susceptibilities
of these active materials to digestion (i.e.
destruction of activity and/or reduction in
molecular size) with a variety of proteo-
lytic enzymes are described here, and sug-
gest that the activities are associated with
short peptide sequences within the pro-
tein molecules, as was postulated earlier
by analogy with the cross-reacting anti-
genic determinant of myelin basic protein
MBP (Caspary & Field, 1971; McDermott
et al., 1974). The material may, of course,
be a glycopeptide, though evidence
(Dickinson & Caspary, 1973) suggests that
the determinant at least is a simple pep-
tide.
The proteolytic susceptibilities suggest
the involvement of aromatic amino acids
in the determinant sequences (peptic and
particularly chymotryptic sensitivity) and
the non-involvement of basic amino acids
except possibly as C-terminal residues
(trypsin stability). The differential effect
of papain in various pH conditions on
tumour-type activity is not readily ex-
plicable in terms of current understanding
of papain specificity (Drenth et al., 1971)
and this point is under investigation. It
seems significant that the activity of
MBP in the MEM test is destroyed by
digestion with papain at pH 7 0, but the
activities of MBP and of the synthetic
determinantpeptide Ser.Arg.Phe.Trp.Gly.-
Ala.Gly-Gln.Arg are retained during diges-
tion at pH 4 0 (Caspary & Dickinson,
unpublished observations).
The ready liberation of (particularly
tumour-type) activity by proteolytic
digestion from viable (dye-excluding) cells
emphasizes the finding that the antigenic
activity is a cell-surface phenomenon
(Dickinson et al., 1972).
Tryptic and papain digestions yield
small, active fragments of the tumour
antigen. The papain fragment is favoured
for further study directed to sequence
analysis. Whereas the active peptide from
tryptic digestion, with its low mobility, is
still mixed with a large amount ofinactive
peptide material, the extraordinarily high
mobility of the papain fragment on paper
in BAW takes it well away from the vast
excess of inactive material in the papain
digest; thus the purification problem is
vastly simplified. This is especially im-
portant in view of the minute amount of
material which appears to be associated
with the activity.
The observation that digestion of ex-
tracts oftumours with non-chymotrypsin-
inhibited trypsin yielded material with
normal tissue antigen-type activity was
originally confusing, but is now clearly
seen to be due to (i) the presence (not sur-
prising in view of the rough dissections of
tumours generally carried out) of normal
tissue antigen in tumour extracts, as
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evidenced by the chromatographic separa-
tion of the two activities after TPCK-
tryptic digestion, and (ii) the relative
stability of the normal tissue activity to
chymotryptic digestion, as evidenced by
the finding ofthis activity on tumour cells
and in supernates after digestion with
crude trypsin. The latter finding strongly
suggests that normal tissue antigen is also
present on the surface of tumour cells.
The failure of active materials to react
with ninhydrin on paper, even though they
are at least partly peptidic in nature, and
the very small amount of material re-
covered in active fractions, even though
activity appears to be recovered in high
yield (manuscript in preparation) suggest
that the tumour and normal tissue anti-
gens constitute only a minute proportion
of the materials extracted with acid. The
uniform behaviour of the tumour-antigen
papain fragment suggests that the anti-
gens from individual tumours may have
identical structures, and justifies the
pooling of materials to obtain sufficient
for structural studies.
The chromatographic separation of
tryptic peptides with tumour-type and
normal tissue-type activity supports the
qualitative distinction between these
cross-reacting activities. The distinction
was originally made solely on the basis of
the quantitatively different plateau show-
ing effects caused, presumably, by release
of qualitatively different lymphokines
from the same sensitized lymphocytes.
This last point may well have implications
beyond the field of tumour immunology.
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